financial post
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
Financial Post • 3 MONTHS AGO
AI shakes up the call center industry, but some tasks are still better left to the humans
Financial Post • 3 MONTHS AGO
A longstanding tax on wealth is a central issue as prosperous Norway votes in a close election
Financial Post • 3 MONTHS AGO
Mozambique embraces a $6 billion electricity project, southern Africa’s biggest in 50 years
Financial Post • 3 MONTHS AGO